Is HCTZ a Diuretic?
Yes, hydrochlorothiazide (HCTZ) is definitively a thiazide diuretic that acts in the distal convoluted tubule of the kidney to inhibit sodium and chloride reabsorption, thereby promoting diuresis and lowering blood pressure. 1, 2, 3
Classification and Mechanism
HCTZ is classified as a thiazide-type diuretic, specifically containing the benzothiadiazine ring structure that distinguishes it from thiazide-like agents (such as chlorthalidone and indapamide). 4
The drug works by inhibiting sodium and chloride reabsorption in the distal convoluted tubule, which is distinct from loop diuretics that act at the loop of Henle and potassium-sparing diuretics that act in the collecting duct. 1
HCTZ promotes urinary sodium excretion and decreases physical signs of fluid retention, with a duration of action of 6-12 hours. 1, 2
Clinical Indications
HCTZ is FDA-approved for the management of hypertension either as monotherapy or in combination with other antihypertensives. 3
The drug is indicated for patients with hypertension and heart failure with mild fluid retention, though loop diuretics are preferred for most heart failure patients with significant congestion. 1
HCTZ becomes ineffective in patients with eGFR <30 mL/min/m², at which point loop diuretics should be used instead. 5
Dosing and Pharmacokinetics
Standard dosing ranges from 25 mg once or twice daily up to a maximum of 200 mg daily, with typical starting doses of 12.5-25 mg in elderly patients. 1, 2, 3
HCTZ has a renal clearance of approximately 18.3 L/h in patients with normal kidney function (creatinine clearance 120 mL/min), but this decreases significantly with renal impairment. 6
The drug has a terminal half-life of approximately 14.8 hours and is primarily eliminated renally via organic anion transporters OAT1 and OAT3. 6, 7
Important Clinical Considerations
HCTZ is less potent than thiazide-like diuretics (chlorthalidone and indapamide) by approximately 4.2-6.2 mm Hg systolic blood pressure on 24-hour measurements. 8
Major guidelines recommend thiazide or thiazide-type diuretics as first-line agents for hypertension, though some expert statements prefer thiazide-like agents (chlorthalidone or indapamide) over HCTZ due to longer duration of action and more robust cardiovascular outcomes data. 9, 10
Common adverse effects include hypokalemia, hypomagnesemia, hyperuricemia, and dilutional hyponatremia, requiring electrolyte monitoring particularly for potassium, sodium, and magnesium levels. 5, 3
Renal function should be carefully monitored, as HCTZ therapy is typically associated with mild increases in blood urea nitrogen and creatinine levels. 5